Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Cancer Res. 2025 Mar 3;85(5):1003. doi: 10.1158/0008-5472.CAN-24-5044.
No abstract available

Publication types

  • Published Erratum